Amarin | AMRN - Zobowiązania





Zobowiązania Zmiana Data
AbbVie USD 42.1B 1.19B 2026-03
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Amarin USD 179.64M 14.82M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
DBV Technologies USD 58.02M 8.54M 2025-12
Esperion Therapeutics USD 300.36M 451K 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
Heron Therapeutics USD 90.52M 5.58M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neurocrine Biosciences USD 831.7M 88.3M 2026-03
Novartis USD 31.37B 4.1B 2026-03